Artal Group S.A. Orchard Therapeutics PLC Transaction History

Artal Group S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	BUY	$4.39 - $9.08 $6.38 Million - $13.2 Million	1,452,358 Added 413.19%	1,803,858 $13.1 Million
Q3 2020 Nov 13, 2020	SELL	$4.11 - $6.45 $76,035 - $119,325	-18,500 Reduced 5.0%	351,500 $1.45 Million
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $172,500 - $359,700	-30,000 Reduced 7.5%	370,000 $2.22 Million
Q1 2020 May 14, 2020	BUY	$5.65 - $15.71 $282,500 - $785,500	50,000 Added 14.29%	400,000 $3.01 Million
Q2 2019 Aug 09, 2019	BUY	$13.2 - $20.63 $4.62 Million - $7.22 Million	350,000 New	350,000 $4.9 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.